N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.65
  • 52 Week Low: 0.55
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 1,674,158
  • Market Cap: £4.99m

Latest ShareCast News

N4 Pharma reports narrower full-year operating loss

By Josh White

Date: Friday 06 Jun 2025

(Sharecast News) - N4 Pharma reported a reduced operating loss of £1.22m for 2024 on Friday, down from £1.42m the prior year, as the biotech company continued to develop its proprietary Nuvec gene delivery platform.

N4 Pharma files for new UK patent

By Josh White

Date: Wednesday 04 Dec 2024

(Sharecast News) - N4 Pharma, a pharmaceutical company specializing in RNA therapeutics, announced the filing of a new patent with the UK patent office on Wednesday, for its oral anti-inflammatory treatment targeting irritable bowel disease (IBD).

N4 Pharma reports positive progress with SRI collaboration

By Josh White

Date: Tuesday 20 Aug 2024

(Sharecast News) - N4 Pharma, a specialist pharmaceutical company focused on the development of Nuvec, a novel delivery system for cancer treatments, gene therapy, and vaccines, updated the market on its collaboration with SRI International on Tuesday.

N4 Pharma shares tank after £0.6m fundraise 07-Jun-2024 ShareCast
N4 Pharma shares jump on latest Nuvec developments 15-Feb-2024 ShareCast
N4 Pharma's Nuvec granted patent in India 19-Jan-2024 ShareCast
N4 Pharma subsidiary agrees work programme for g... 16-Jan-2024 ShareCast
N4 Pharma reports progress in Nuvec clinical res... 08-Jan-2024 ShareCast
N4 Pharma upbeat on recent Nuvec developments 18-Dec-2023 ShareCast
N4 Pharma posts optimistic Nuvec research update 07-Dec-2023 ShareCast
N4 Pharma picks up controlling interest in Nanog... 28-Sep-2023 ShareCast
N4 Pharma reports progress with siRNA work 18-Apr-2023 ShareCast
N4 Pharma shares tumble following placing, broke... 18-Nov-2022 ShareCast
N4 Pharma reports success in recent 'Nuvec' test... 04-Oct-2022 ShareCast
N4 Pharma reduces losses as Nuvec development co... 29-Sep-2022 ShareCast
N4 Pharma upbeat on latest tumour suppression st... 15-Jul-2022 ShareCast
N4 Pharma outlines work plan after 'encouraging'... 25-Jan-2022 ShareCast
N4 upbeat on cancer treatment progress, vaccine ... 13-Dec-2021 ShareCast
N4 Pharma granted Europe patent with China equiv... 01-Oct-2021 ShareCast
N4 Pharma losses widen as it works on commercial... 24-Feb-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.65
52 Week Low 0.55
Volume 1,674,158
Shares Issued 832.28m
Market Cap £4.99m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 17-Oct-2025

Time Volume / Share Price
15:10 837,334 @ 0.57p
13:00 7,069 @ 0.65p
13:00 25,232 @ 0.55p
10:31 2,727 @ 0.55p
10:31 769 @ 0.65p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page